Effects of Enalapril on Mortality in Severe Congestive Heart Failure

New England Journal of Medicine

Volumn 316, Issue 23, 1987, Pages 1429-1435

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019316271     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198706043162301     Document Type: Article

References (26)

1. McFate Smith W. Epidemiology of congestive heart failure. Am J Cardiol 1985; 55: Suppl A: 3A–8A.
2. Applefeld MM. Chronic congestive heart failure: Where have we been? Where are we heading? Am J Med 1986; 80: Suppl 2B: 73–7.
3. Franciosa JA, Mikulic E, Cohn JN, Jose E, Fabie A. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation 1974; 50: 1020–4.
4. Chatterjee K, Parmley WW, Massie B, et al. Oral hydralazine therapy for chronic refractory heart failure. Circulation 1976; 54: 879–83.
5. Packer M. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. J Am Coll Cardiol 1983; 2: 841–52.
6. Levine TB. Role of vasodilators in the treatment of congestive heart failure. Am J Cardiol 1985; 55: Suppl A: 32A–35A.
7. Braunwald E, Colucci WS. Vasodilator therapy of heart failure: has the promissory note been paid? N Engl J Med 1984; 310: 459–61.
8. Abrams J. Vasodilator therapy for chronic congestive heart failure. JAMA 1985; 254: 3070–4.
9. Lipkin DP, Poole-Wilson PA. Treatment of chronic heart failure: a review of recent drug trials. Br Med J 1985; 291: 993–6.
10. Furberg CD, Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol 1985; 55: 1110–3.
11. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314: 1547–52.
12. Todd PA, Heel RC. Enalapril: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1986; 31: 198–248.
13. Jonsell S. A method for the determination of the heart size by teleroentgenography (a heart volume index). Acta Radiol 1939; 20: 325–40.
14. Gillum RF. Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1985; 108: 150–8.
15. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947; 12: 153–7.
16. McCullagh P. Regression models for ordinal data. J R Stat Soc 1980; 42: 109–42.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. I Am Stat Assoc 1958; 53: 457–81.
18. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel–Haenzel procedure. J Am Stat Assoc 1963; 58: 690–700.
19. Cox DR. Regression methods and life tables. JR Stat Soc (B) 1972; 34: 187–220.
20. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 1985; 72: 681–5.
21. Cleland JGF, Dargie HJ, McAlpine H, et al. Severe hypotension after first dose of enalapril in heart failure. Br Med I 1985; 291: 1309–12.
22. Packer M, Kessler PD, Gottlieb SS. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. Postgrad Med J 1986; 62: Suppl 1: 179–82.
23. Funck-Brentano C, Chatellier G, Alexandre J-M. Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure. Br Heart J 1986; 55: 596–8.
24. Pfeffer MA, Pfeffer JM, Steinburg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985; 72: 406–12.
25. Bayliss J, Norell MS, Canepa-Anson R, Reid C, Poole-Wilson P, Sutton G. Clinical importance of the renin-angiotensin system in chronic heart failure: double-blind comparison of captopril and prazosin. Br Med J 1985; 290: 1861–5.
26. Ueda K, Sakai M, Matsushita S, Kuwajima I, Murakami M. Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure. Jpn Heart J 1983; 24: 711–21.